Amplifications of EGFR and gain of chromosomes 19 and 20 were strongly prevalent in RTK II, and PDGFRA, CDK4 and MDM2 or MDM4 amplifications were more frequent in RTK I tumours (Fig. 1b). The gene discussed is MDM4; the disease is neoplasm.